• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Ivy Brain Tumor Center Announces Initial Results of Pamiparib Newly-Diagnosed

    GLOBENEWSWIRE

    BeiGene Announces Inclusion in the China National Reimbursement Drug List (NRDL)

    PRESS RELEASE

    BeiGene Announces Inclusion in the China National Reimbursement Drug List

    BUSINESSWIRE

    BeiGene Announces Data on Tislelizumab & Pamiparib to at the 2020

    GLOBENEWSWIRE

    Priority Review Granted to BeiGene’s New Drug Application of Pamiparib

    GLOBENEWSWIRE

    BMS gets the ball rolling on liso-cel Europe; BeiGene files China NDA PARP drug

    ENDPTS

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.